Clinical trials in Epagny Metz Tessy – page 3

48 clinical trials in Epagny Metz Tessy, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in FranceEssaisCliniques.fr

Epagny Metz Tessy at a glance

clinical trials

Paediatric trials0
Research sites0

Quick filters

48 trials in Epagny Metz Tessy

Open in trial search

Study on the Safety and Immune Response of the 20-Valent Pneumococcal Vaccine in Adults with Fever and High Risk for Pneumococcal Infection

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
Sponsor:Centre Hospitalier Universitaire De Saint Etienne

Contact Research Centre

Study Comparing Rifabutin and Rifampicin for Adults with Staphylococcal Prosthetic Joint Infection Using DAIR Strategy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Rifabutin
Sponsor:Centre Hospitalier De Tourcoing

Contact Research Centre

Study of Dostarlimab Combined with Short Course Radiotherapy for Locally Advanced Rectal Cancer Patients with Microsatellite Instability

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Dostarlimab
Sponsor:Centre Hospitalier Universitaire De Dijon

Contact Research Centre

Study on the Effects of Ticagrelor and Rivaroxaban in Patients with Atrial Fibrillation After Coronary Stent Surgery

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Insel Gruppe AG

Contact Research Centre

Study on Using Oxaliplatin, Fluorouracil, and Folinic Acid for Treating Stage II Colon Cancer in Patients with Positive Circulating Tumor DNA

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Fluorouracil
Sponsor:Centre Hospitalier Universitaire De Dijon

Contact Research Centre

Study on the Effect of Hydroxychloroquine for Patients with IgA Nephropathy and High Albumin Levels

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Hydroxychloroquine Sulfate
Sponsor:Centre Hospitalier Universitaire De Saint Etienne

Contact Research Centre

Study of drug combination therapy in asymptomatic patients with frequent premature ventricular contractions and normal heart function to prevent left ventricular dysfunction

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bisoprolol Fumarate
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Study on Cabozantinib and Drug Combination for Untreated Metastatic Renal Cell Carcinoma in Intermediate and Poor Risk Patients

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Axitinib
Sponsor:Institut Gustave Roussy

Contact Research Centre

Atypical mycobacterial infection

Recruiting

Registered drugNo placebo

Study on Amikacin for Treating Mycobacterium Xenopi Lung Infection in Patients Using Amikacin and Drug Combination

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Amikacin
Sponsor:Centre Hospitalier Universitaire Amiens Picardie

Contact Research Centre

A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

Investigational

France

Participants:18–64 years · 65+ years
Sponsor:Eli Lilly & Co.

Contact Research Centre

Study of nemtabrutinib combined with venetoclax and obinutuzumab in untreated CLL/SLL patients with TP53 alterations

Not yet recruiting

Registered drugNo placebo

Study of nemtabrutinib combined with venetoclax and obinutuzumab in untreated CLL/SLL patients with TP53 alterations

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Nemtabrutinib
Sponsor:French Innovative Leukemia Organization (F.I.L.O.).

Contact Research Centre

Pyelonephritis

Not yet recruiting

Registered drugNo placebo

Fosfomycin trometamol versus drug combination for treating acute E. coli pyelonephritis in women aged 75 years and older

Registered drugNo placebo

France

Participants:65+ years
Substances:Amikacin Sulfate
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Epagny Metz Tessy

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on multiple myeloma treatments, exploring new therapeutic combinations and maintenance strategies. Studies include evaluations of esophageal squamous cell carcinoma and advanced approaches for triple-negative breast cancer.

Multiple Myeloma Treatments
Esophageal Cancer Therapy
Breast Cancer Management

Several trials are investigating immunotherapy combinations and targeted treatments for various cancer types.

02 Cardiovascular Studies

Research focusing on innovative approaches to treat patients with atrial fibrillation post-coronary intervention, and new protocols for managing acute ischemic stroke.

Anticoagulation Strategies
Stroke Prevention
Post-PCI Management

Trials aim to optimize antithrombotic treatments and improve patient outcomes.

03 Immunology and Infectious Diseases

Studies evaluating treatments for granulomatosis with polyangiitis and investigating novel approaches to prosthetic joint infections. Important research on pneumococcal vaccine effectiveness in high-risk populations.

Autoimmune Conditions
Infection Management
Vaccine Studies

Focus on developing more effective treatments for both acute and chronic conditions.

Back to France All countries

Clinical trials in Epagny Metz Tessy – page 3

48 trials in Epagny Metz Tessy

Pyrexia+1

Study on the Safety and Immune Response of the 20-Valent Pneumococcal Vaccine in Adults with Fever and High Risk for Pneumococcal Infection

Device related infection

Study Comparing Rifabutin and Rifampicin for Adults with Staphylococcal Prosthetic Joint Infection Using DAIR Strategy

Rectal cancer+2

Study of Dostarlimab Combined with Short Course Radiotherapy for Locally Advanced Rectal Cancer Patients with Microsatellite Instability

Atrial fibrillation+3

Study on the Effects of Ticagrelor and Rivaroxaban in Patients with Atrial Fibrillation After Coronary Stent Surgery

Colon cancer

Study on Using Oxaliplatin, Fluorouracil, and Folinic Acid for Treating Stage II Colon Cancer in Patients with Positive Circulating Tumor DNA

IgA nephropathy

Study on the Effect of Hydroxychloroquine for Patients with IgA Nephropathy and High Albumin Levels

Ventricular extrasystoles

Study of drug combination therapy in asymptomatic patients with frequent premature ventricular contractions and normal heart function to prevent left ventricular dysfunction

Renal cell carcinoma

Study on Cabozantinib and Drug Combination for Untreated Metastatic Renal Cell Carcinoma in Intermediate and Poor Risk Patients

Atypical mycobacterial infection

Study on Amikacin for Treating Mycobacterium Xenopi Lung Infection in Patients Using Amikacin and Drug Combination

Arteriosclerosis

A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

Study of nemtabrutinib combined with venetoclax and obinutuzumab in untreated CLL/SLL patients with TP53 alterations

Study of nemtabrutinib combined with venetoclax and obinutuzumab in untreated CLL/SLL patients with TP53 alterations

Pyelonephritis

Fosfomycin trometamol versus drug combination for treating acute E. coli pyelonephritis in women aged 75 years and older

Filter the trials

Other cities in France

Clinical research in Epagny Metz Tessy

Prefer not to search? Our Concierge searches the trials for you.

Clinical trials in Epagny Metz Tessy – page 3

48 trials in Epagny Metz Tessy

Pyrexia+1

Rectal cancer+2

Atrial fibrillation+3

Other cities in France

Related

Clinical research in Epagny Metz Tessy

Prefer not to search? Our Concierge searches the trials for you.